Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0005 par value
-
Shares outstanding
-
25,109,479
-
Total 13F shares
-
292,343
-
Share change
-
+237,076
-
Total reported value
-
$433,012
-
Price per share
-
$1.48
-
Number of holders
-
8
-
Value change
-
+$351,218
-
Number of buys
-
6
Institutional Holders of Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value (MHUA) as of Q4 2023
As of 31 Dec 2023,
Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value (MHUA) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
292,343 shares.
The largest 8 holders included
MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, MORGAN STANLEY, UBS Group AG, and Tower Research Capital LLC (TRC).
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.